US Map / Texas
State TX

Clinical Trials in Texas

Texas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Texas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 745 actively recruiting studies with Texas sites out of 745 registered in total. The busiest research areas in Texas are Advanced Solid Tumor, Breast Cancer, Ovarian Cancer. Leading sponsors running trials in the state include M.D. Anderson Cancer Center, The University of Texas Health Science Center, Houston, University of Texas Southwestern Medical Center. By stage, Texas trials break down as Phase 1 (174), Phase 2 (201), Phase 3 (137), Phase 4 (16).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
745
Recruiting Now
745
← Back to US Map
Top Conditions in Texas
Advanced Solid Tumor (16)Breast Cancer (13)Ovarian Cancer (10)Acute Myeloid Leukemia (10)Non Small Cell Lung Cancer (8)Colorectal Cancer (8)Heart Failure (8)Cancer (8)Solid Tumor (7)Prostate Cancer (7)Non-Small Cell Lung Cancer (7)Advanced Solid Tumors (7)

Frequently Asked Questions — Clinical Trials in Texas

How many clinical trials are currently recruiting in Texas?
ClinicalMetric currently tracks 745 actively recruiting clinical trials with at least one location in Texas. The total number of registered studies—including active but not currently enrolling trials—is 745. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Texas?
Texas hosts clinical trials across a broad range of medical conditions, including Advanced Solid Tumor, Breast Cancer, Ovarian Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Texas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Texas?
To join a clinical trial in Texas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Texas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Texas

NCT00488878 N/A
Recruiting
Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
Condition
Low Grade Ovarian Serous Adenocarcinoma
Enrollment
2,000 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07220876 N/A
Recruiting
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refract...
Condition
Open Angle Glaucoma (OAG)
Enrollment
165 pts
Location
United States, South Africa
Sponsor
Avisi Technologies Inc.
View Trial →
NCT07075718 Phase 2, Phase 3
Recruiting
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generati...
Condition
Glaucoma
Enrollment
610 pts
Location
United States
Sponsor
Glaukos Corporation
View Trial →
NCT06545955 Phase 3
Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combinatio...
Condition
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Enrollment
250 pts
Location
United States, Canada, Czechia
Sponsor
Ferring Pharmaceuticals
View Trial →
NCT07612878 N/A
Recruiting
The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated W...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
350 pts
Location
United States
Sponsor
Sanofi
View Trial →
NCT03424005 Phase 1, Phase 2
Recruiting
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in...
Condition
Metastatic Breast Cancer
Enrollment
1,132 pts
Location
United States, Australia, France
Sponsor
Hoffmann-La Roche
View Trial →
NCT04777994 Phase 1
Recruiting
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumo...
Condition
Advanced Solid Tumor Cancer
Enrollment
248 pts
Location
United States, France, Israel
Sponsor
Calico Life Sciences LLC
View Trial →
NCT05868629 N/A
Recruiting
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In...
Condition
Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors
Enrollment
40 pts
Location
United States
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06858319 Phase 3
Recruiting
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Condition
Kidney Diseases
Enrollment
220 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07609394 N/A
Recruiting
Duchenne Electronic Health Record Study
Condition
Duchenne Muscular Dystrophy (DMD)
Enrollment
2,500 pts
Location
United States
Sponsor
The Duchenne Registry
View Trial →
NCT04366531 N/A
Recruiting
Successful Transitions and Reintegration Tools for Veterans (START-VETS)
Condition
Substance Use Disorder
Enrollment
20 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT06672575 Phase 1, Phase 2
Recruiting
A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
Condition
Glioblastoma
Enrollment
45 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07532265 Phase 2
Recruiting
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in...
Condition
Severe Asthma
Enrollment
512 pts
Location
United States
Sponsor
Kinaset Therapeutics Inc
View Trial →
NCT07085767 Phase 3
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/...
Condition
Breast Cancer
Enrollment
1,000 pts
Location
United States, Australia, Austria
Sponsor
Olema Pharmaceuticals, Inc.
View Trial →
NCT05439200 N/A
Recruiting
Video Treatment for Amblyopia
Condition
Amblyopia
Enrollment
44 pts
Location
United States
Sponsor
Retina Foundation of the South
View Trial →
NCT04951622 Phase 3
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Condition
Myasthenia Gravis
Enrollment
199 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
View Trial →
NCT06450353 N/A
Recruiting
Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation
Condition
Allogeneic Transplantation
Enrollment
1,200 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07712575 Phase 1
Recruiting
A Study of V132 in Healthy Older Participants (V132-001)
Condition
Healthy
Enrollment
280 pts
Location
United States
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06150157 Phase 1
Recruiting
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myelopr...
Condition
Neoplasms
Enrollment
300 pts
Location
United States, Canada, China
Sponsor
Janssen Research & Development
View Trial →
NCT06324357 Phase 1, Phase 2
Recruiting
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in...
Condition
Metastatic Breast Cancer
Enrollment
768 pts
Location
United States, Belgium, China
Sponsor
Boehringer Ingelheim
View Trial →
NCT04696029 Phase 2
Recruiting
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medul...
Condition
Medulloblastoma
Enrollment
118 pts
Location
United States, Canada
Sponsor
Giselle Sholler
View Trial →
NCT06014502 Phase 1
Recruiting
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Adv...
Condition
Solid Tumor
Enrollment
105 pts
Location
United States
Sponsor
ImmunoGenesis
View Trial →
NCT07197645 Phase 1
Recruiting
Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain
Condition
Bone Pain
Enrollment
33 pts
Location
United States
Sponsor
Telix Pharmaceuticals (Innovat
View Trial →
NCT05659381 Phase 3
Recruiting
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary P...
Condition
Stage III Ovarian Cancer
Enrollment
220 pts
Location
United States
Sponsor
GOG Foundation
View Trial →
NCT05827081 Phase 3
Recruiting
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Condition
Early Breast Cancer
Enrollment
1,400 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
View Trial →
Page 4 of 30 — 745 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology